...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: BIO Investor Forum, Oct 22-23

,,,,yep,,,and Sarah called me back to say they were put up on the web site,,,,,,,,and they are there as noted.

Share
New Message
Please login to post a reply